vs

Side-by-side financial comparison of Graham Holdings Co (GHC) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.

HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.1× Graham Holdings Co). Graham Holdings Co runs the higher net margin — 8.7% vs 7.3%, a 1.4% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs 0.4%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $5.0M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 4.2%).

Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

GHC vs HAE — Head-to-Head

Bigger by revenue
HAE
HAE
1.1× larger
HAE
$1.3B
$1.3B
GHC
Growing faster (revenue YoY)
HAE
HAE
+4.4% gap
HAE
4.8%
0.4%
GHC
Higher net margin
GHC
GHC
1.4% more per $
GHC
8.7%
7.3%
HAE
More free cash flow
HAE
HAE
$204.9M more FCF
HAE
$209.9M
$5.0M
GHC
Faster 2-yr revenue CAGR
HAE
HAE
Annualised
HAE
99.2%
4.2%
GHC

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
GHC
GHC
HAE
HAE
Revenue
$1.3B
$1.3B
Net Profit
$108.7M
$97.3M
Gross Margin
14.9%
Operating Margin
3.8%
83.4%
Net Margin
8.7%
7.3%
Revenue YoY
0.4%
4.8%
Net Profit YoY
-80.2%
-42.0%
EPS (diluted)
$24.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GHC
GHC
HAE
HAE
Q1 26
$1.3B
Q4 25
$1.3B
$339.0M
Q3 25
$1.3B
$327.3M
Q2 25
$1.2B
$321.4M
Q1 25
$1.2B
$330.6M
Q4 24
$1.2B
$348.5M
Q3 24
$1.2B
$345.5M
Q2 24
$1.2B
$336.2M
Net Profit
GHC
GHC
HAE
HAE
Q1 26
$97.3M
Q4 25
$108.7M
$44.7M
Q3 25
$122.9M
$38.7M
Q2 25
$36.7M
$34.0M
Q1 25
$23.9M
$58.0M
Q4 24
$548.8M
$37.5M
Q3 24
$72.5M
$33.8M
Q2 24
$-21.0M
$38.4M
Gross Margin
GHC
GHC
HAE
HAE
Q1 26
14.9%
Q4 25
59.7%
Q3 25
59.5%
Q2 25
59.8%
Q1 25
58.4%
Q4 24
55.5%
Q3 24
54.2%
Q2 24
52.0%
Operating Margin
GHC
GHC
HAE
HAE
Q1 26
83.4%
Q4 25
3.8%
19.9%
Q3 25
5.2%
17.9%
Q2 25
6.0%
16.8%
Q1 25
4.1%
21.6%
Q4 24
5.8%
16.9%
Q3 24
6.8%
15.0%
Q2 24
2.2%
11.8%
Net Margin
GHC
GHC
HAE
HAE
Q1 26
7.3%
Q4 25
8.7%
13.2%
Q3 25
9.6%
11.8%
Q2 25
3.0%
10.6%
Q1 25
2.0%
17.5%
Q4 24
44.1%
10.8%
Q3 24
6.0%
9.8%
Q2 24
-1.8%
11.4%
EPS (diluted)
GHC
GHC
HAE
HAE
Q1 26
Q4 25
$24.76
$0.95
Q3 25
$27.91
$0.81
Q2 25
$8.35
$0.70
Q1 25
$5.45
$1.17
Q4 24
$124.05
$0.74
Q3 24
$16.42
$0.66
Q2 24
$-4.79
$0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GHC
GHC
HAE
HAE
Cash + ST InvestmentsLiquidity on hand
$267.0M
$245.4M
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$4.8B
$796.3M
Total Assets
$8.4B
$2.4B
Debt / EquityLower = less leverage
1.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GHC
GHC
HAE
HAE
Q1 26
$245.4M
Q4 25
$267.0M
$363.4M
Q3 25
$190.8M
$296.4M
Q2 25
$176.2M
$292.9M
Q1 25
$156.7M
$306.8M
Q4 24
$260.9M
$320.8M
Q3 24
$244.4M
$299.3M
Q2 24
$140.7M
$344.4M
Total Debt
GHC
GHC
HAE
HAE
Q1 26
$1.2B
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
Q3 24
Q2 24
Stockholders' Equity
GHC
GHC
HAE
HAE
Q1 26
$796.3M
Q4 25
$4.8B
$911.5M
Q3 25
$4.5B
$849.2M
Q2 25
$4.4B
$882.3M
Q1 25
$4.3B
$820.8M
Q4 24
$4.3B
$906.9M
Q3 24
$4.0B
$878.9M
Q2 24
$4.0B
$905.4M
Total Assets
GHC
GHC
HAE
HAE
Q1 26
$2.4B
Q4 25
$8.4B
$2.5B
Q3 25
$7.9B
$2.4B
Q2 25
$7.6B
$2.5B
Q1 25
$7.6B
$2.5B
Q4 24
$7.7B
$2.5B
Q3 24
$7.4B
$2.5B
Q2 24
$7.2B
$2.5B
Debt / Equity
GHC
GHC
HAE
HAE
Q1 26
1.53×
Q4 25
1.34×
Q3 25
1.44×
Q2 25
1.39×
Q1 25
1.49×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GHC
GHC
HAE
HAE
Operating Cash FlowLast quarter
$28.3M
$293.2M
Free Cash FlowOCF − Capex
$5.0M
$209.9M
FCF MarginFCF / Revenue
0.4%
15.7%
Capex IntensityCapex / Revenue
1.9%
2.5%
Cash ConversionOCF / Net Profit
0.26×
3.01×
TTM Free Cash FlowTrailing 4 quarters
$275.3M
$417.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GHC
GHC
HAE
HAE
Q1 26
$293.2M
Q4 25
$28.3M
$93.6M
Q3 25
$178.1M
$111.3M
Q2 25
$94.8M
$17.4M
Q1 25
$46.0M
$116.6M
Q4 24
$116.3M
$43.8M
Q3 24
$237.6M
$48.8M
Q2 24
$52.0M
$-27.4M
Free Cash Flow
GHC
GHC
HAE
HAE
Q1 26
$209.9M
Q4 25
$5.0M
$87.2M
Q3 25
$161.8M
$106.3M
Q2 25
$78.0M
$13.6M
Q1 25
$30.5M
$100.9M
Q4 24
$91.1M
$35.2M
Q3 24
$219.4M
$39.4M
Q2 24
$33.7M
$-33.1M
FCF Margin
GHC
GHC
HAE
HAE
Q1 26
15.7%
Q4 25
0.4%
25.7%
Q3 25
12.6%
32.5%
Q2 25
6.4%
4.2%
Q1 25
2.6%
30.5%
Q4 24
7.3%
10.1%
Q3 24
18.2%
11.4%
Q2 24
2.8%
-9.8%
Capex Intensity
GHC
GHC
HAE
HAE
Q1 26
2.5%
Q4 25
1.9%
1.9%
Q3 25
1.3%
1.5%
Q2 25
1.4%
1.2%
Q1 25
1.3%
4.7%
Q4 24
2.0%
2.5%
Q3 24
1.5%
2.7%
Q2 24
1.5%
1.7%
Cash Conversion
GHC
GHC
HAE
HAE
Q1 26
3.01×
Q4 25
0.26×
2.09×
Q3 25
1.45×
2.88×
Q2 25
2.58×
0.51×
Q1 25
1.93×
2.01×
Q4 24
0.21×
1.17×
Q3 24
3.28×
1.44×
Q2 24
-0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GHC
GHC

Products$602.7M48%
Kaplan International$251.9M20%
Manufacturing$117.8M9%
Television Broadcasting$110.5M9%
Higher Education$83.8M7%
Supplemental Education$74.9M6%
Related Party$4.4M0%

HAE
HAE

Segment breakdown not available.

Related Comparisons